Loading
Latest filing published 20 Apr 2026 for 티앤알바이오팹, €16k.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
김영필 is a declared insider of 티앤알바이오팹 (chief executive), with filings sourced from DART (FSS). Over a trading history stretching from 30 October 2025 to 14 April 2026, the count stands at 3 filings.
Purchases make up the whole of the open-market record (3 purchases, €16k). The amount is not disclosed for 2 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2026: 2 purchases and no sales on the market.
The record was last updated on 20 April 2026 with an open-market purchase (€16k) in 티앤알바이오팹. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.